Serial 98239940
Live / Registered — Registered (as of 12 Aug 2025)
What this means for you
Registered since 12 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98239940
- Registration number
- 7893041
- Mark type
- Design / logo
- Filed
- 25 Oct 2023
- Published for opposition
- 16 Jul 2024
- Registered
- 12 Aug 2025
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions
Owner
- OPUS GENETICS, INC., DURHAM, NC, US
- OPUS GENETICS, INC., DURHAM, NC, US
- OCUPHIRE PHARMA, INC., FARMINGTON HILLS, MI, US
- OCUPHIRE PHARMA, INC., FARMINGTON HILLS, MI, US
Prosecution history
- 12 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jul 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jan 2025 — USE AMENDMENT FILED
- 11 Apr 2025 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 11 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Apr 2025 — ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
- 04 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Apr 2025 — ASSIGNED TO EXAMINER
- 26 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED